Martha A. Nance

Martha Nance practices at Methodist Hospital in Saint Louis Park, Minnesota, part of HealthPartners.

Martha Nance's NPI, 1457338592, was assigned on December 29, 2005. Martha Nance graduated from Virginia Commonwealth University, School of Medicine in 1984. Martha Nance holds Minnesota license 31557.

Martha Nance's primary practice is Methodist Hospital, at 6500 Excelsior Blvd, Saint Louis Park, MN 55426 in Hennepin County. The practice phone is (952) 993-5000.

Martha Nance's primary practice is Methodist Hospital in Saint Louis Park, Minnesota, part of HealthPartners. Martha Nance is also affiliated with Hennepin County Medical Center. The medical group on file is Park Nicollet Clinic. Dmand AI also links Martha Nance to 2 more hospitals, 1 group practice or clinic, 1 home health agency and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Martha Nance practices, 6 sites in all. Vendor and product names are available with a free account.

Neurology is Martha Nance's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Martha Nance is licensed in Minnesota.

CMS data shows 629 Medicare services from Martha Nance across 7 procedure codes in 2024, for 354 Medicare patients. Medicare paid $38,833 for them.

CMS counts 354 Medicare patients who saw Martha Nance in 2024. The largest group is 65 to 74, with 145 patients. 75% of them have parkinson's disease, and 54% have high cholesterol. 12% are also on Medicaid. Their average risk score is 1.43, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Martha Nance's median patient age at 72, with 46% women.

In 2024, Martha Nance wrote 5,406 Medicare Part D claims for 710 patients. 90% of them were for generic drugs. CMS names the drug for 5,225 of them, across 50 drugs with 11 or more claims each, at $2,015,330 in total drug cost. In 2023, CMS named 5,370 claims across 51 drugs.

Martha Nance accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Martha Nance as offering telehealth.

Dmand AI links 28 papers to Martha Nance, published from 2016 to 2024. 2023 was the busiest year, with 5. The most frequent topics are Huntington Disease, Parkinson Disease and Genetic Testing. Martha Nance has published most often in Genet Med. Martha Nance's most frequent co-authors are Roy Nissim Alcalay, MD, David F. Cella, PhD and Karen S. Marder, MD.

Dmand AI links Martha Nance to 1 clinical trial. Conditions studied include Huntington Disease and Chorea. Open Payments lists research payments to Martha Nance that name 1 trial.

CMS Open Payments shows 33 general payments to Martha Nance from 7 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 77% of the total. Genentech, Inc. paid the most, $25,308. It also lists 8 research payments totaling $3,451 from 2020 to 2021, naming 1 clinical trial.

Martha Nance graduated from Virginia Commonwealth University, School of Medicine in 1984.